#drug discovery

OpenAI has introduced GPT-Rosalind, a purpose-built reasoning model for life sciences research, aiming to support tasks from genomics and protein work to hypothesis generation and early drug discovery

New neuron-level mapping work highlights how pain-sensing cells are organized, offering a clearer starting point for future chronic inflammatory pain therapies.

Scientists have created a molecular map of a human receptor involved in blood clotting and inflammation, a finding that could support better drug development for heart and lung diseases.

Rockefeller University researchers built MultiQ-IT, a mass spectrometry device that processes billions of molecules in parallel, achieving 100-fold better sensitivity and potentially transforming drug discovery.

AI models are evolving from research assistants into genuine scientific co-investigators, with hypotheses now being validated in organoids, animal models, and early-stage clinical trials, according to Nature Medicine.

Indiana University researchers discovered that age-related blood mutations may drive severe inflammatory bowel disease, identifying a potential new drug target for Crohn's and colitis.

Researchers have pinpointed a molecular weak spot in anti-NMDA receptor encephalitis, the devastating autoimmune condition known as 'Brain on Fire.' The discovery opens the door to targeted therapies for a disease that attacks memory and cognition, causing psychiatric symptoms, seizures, and death.